Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Edward J. Benz Jr., MD
Researcher President and CEO Emeritus
Dana-Farber Cancer Institute
450 Brookline Avenue
Dana 1628
Boston, Massachusetts, United States
Dr. Benz graduated from Harvard Medical School in 1973 and received his training at Brigham and Women’s Hospital and the National Institutes of Health. He is president and CEO emeritus of Dana-Farber Cancer Institute, director emeritus and principal investigator of Dana-Farber/Harvard Cancer Center, and a member of the Governing Board of Dana-Farber/Children’s Cancer Center. He is also a clinical hematologist and an active NIH-funded investigator. He is the Richard and Susan Smith Distinguished Professor of Medicine, Professor of Pediatrics, Professor of Genetics, Harvard Medical School.
Dr. Benz is an internationally recognized hematologist and an active National Institutes of Health-funded Investigator. His laboratory studies focus on molecular regulation and functions of membrane cytoskeletal proteins that were originally discovered in the red blood cell. He has authored more than 300 peer reviewed articles, reviews, chapters, and abstracts. He is Co-editor of “Hematology: Principles and Practice,” which received the First Place Award for Textbooks from the British Medical Journal and of the “Oxford Textbook of Medicine,” for which he and his colleagues received the Royal Society of Authors Textbook Award. He is an Associate Editor of the New England Journal of Medicine.
Representative Publications:
Molecular genetics of the sickling syndromes: evolution of new strategies for improved diagnosis
Newborn screening for α-thalassemia–keeping up with globalization
Learning about genomics and disease from the anucleate human red blood cell
+myBinderRelated Content
-
Tim Townes, PhDTim M. Townes (b.1951), Professor and Ch...
-
Why do blood types matter? – Natalie S. Hodgehttps://www.youtube.com/watch?v=xfZhb6lm...
-
Marc Stuart Zumberg, MDDr. Zumberg is recognized as an outstand...
-
The 2020 ASPHO Conference – CANCELEDMore than 1,200 pediatric hematology/onc...
-
Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2022The Annual Scientific Conference on Sick...
-
Foundation for Women & Girls with Blood DisordersIn 2010, the Foundation for Women & ...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
